Incorporating Digital Biomarkers into ALS Trials to be Utilized as Clinically Acceptable Endpoints
Time: 1:30 pm
day: Day One Track B PM
Details:
- Optimizing the use of digital biomarkers to help detect minor changes that ALSFRS-R scale cannot detect
- Maximizing the deployment of real-life digital biomarker read-outs
- Extending the application of digital measurements beyond their role as exploratory endpoints
